LiMing Yang

LiMing Yang

Auto-generated profile, based on publicly available information

LiMing Yang

Department of Skin and Venereal Diseases, Jincheng People’s Hospital, Jincheng, China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 October 2023 in BMC Cancer
Verified
Journal Article
Open access
PDF file
BZBin Zhang
Bin Zhang
DHDali Han
Dali Han
LYLiMing Yang
LiMing Yang
YHYang He
Yang He
SYShujun Yang
Shujun Yang
PSpanfeng shang
panfeng shang
Background: Mitofusin 2 (MFN2) plays an important role in many tumors, but how its role in renal clear cell carcinoma needs further research. Methods: In this study, we analyzed the expression of MFN2 in renal clear cell carcinoma tissues and normal kidney tissues through the Cancer Genome Atlas (TCGA) database and our clinical samples.Enrichment analysis was performed to determine MFN2-related pathways and biological functions. The correlation of MFN2 expression with immune cells was analyzed.The correlation of the expression of methylation and the methylation sites of MFN2 were analyzed by UALCAN and TCGA databases. Univariate / multivariate COX risk regression and Kaplan-Meier methods were used to determine the prognostic value of MFN2.Nomograms were drawn to predict overall survival (OS) at 1,3, and 5 years. We investigated the role of MFN2 in renal cancer cells using CCK 8, clone formation, wound healing assay, and methylase qPCR experiments. Results: MFN2 is poorly expressed in renal clear cell carcinoma compared to normal kidney tissue,and is significantly negatively associated with TNM stage, histological grade and pathological stage.MFN2 was directly associated with OS after multivariate Cox regression analysis.MFN2 shows a hypomethylation state and shows a positive correlation with multiple methylation sites.Signaling pathways through functional enrichment to B-cell receptors and oxidative stress-induced senescence.Moreover, the low expression of MFN2 was positively correlated with the degree of immune cell infiltration in a variety of immune cells.In vitro experiments showed that overexpression of MFN2 significantly inhibited the proliferation and migration of renal clear cells and promoted methylation. Conclusions: In conclusion, MFN2 can be used as a novel prognostic marker for renal clear cell carcinoma and requires further investigation of its role in tumor development.

14 December 2022 in Therapeutic Apheresis and Dialysis
Verified
Journal Article
Closed access
SLShichen Liu
Shichen Liu
LYLiming Yang
Liming Yang
XZXueyan Zhu
Xueyan Zhu
XZXiaoxuan Zhang
Xiaoxuan Zhang
LMLingfei Meng
Lingfei Meng
WCWenpeng Cui
Wenpeng Cui